Streetbeat News

Products Services

BLFS

BioLife Solutions has received CAP-BAP accreditation for all its SciSafe U.S. biostorage facilities from the College of American Pathologists. This accreditation ensures the highest quality standards for biostorage services.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 12:06 pm

WLDS

Wearable Devices Ltd. (NASDAQ: WLDS) announces its Asia Pacific Technology Showcase to expand partnerships for its wearable sensing technology. The company aims to foster partnerships with leading producers in Japan, Taiwan, and China, integrating its Mudra technology into various products.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 12:04 pm

PFE

Pfizer warns of potential shortages for pediatric Bicillin L-A, an antibiotic for syphilis treatment, by the end of June due to prioritizing adult versions amid a surge in syphilis infections. The company's penicillin products have been experiencing shortages since April, and another penicillin product, Bicillin C-R, is expected to face supply depletion in Q3.

Portfolio Pulse from Vandana Singh

June 14, 2023 | 12:03 pm

PXMD

PaxMedica has submitted a request to South Africa's SAHPRA for approval to conduct a double-blind, placebo-controlled study, PAX-ASD-101, for the treatment of Autism Spectrum Disorder (ASD). The trial aims to enroll 30 subjects aged 4 to 18 and is expected to begin in Q4 2023. PaxMedica is also preparing additional submissions for planned PAX-101 trials with other regulatory authorities outside of South Africa in 2023.

Portfolio Pulse from Happy Mohamed

June 14, 2023 | 12:02 pm

IOBT

MRK

IO Biotech has reached a significant milestone by randomizing 225 patients in its global Phase 3 clinical trial for IO102-IO103, in combination with Merck's pembrolizumab, for advanced melanoma patients. The trial protocol calls for an interim analysis of overall response rate one year after 225 patients have been enrolled. If positive, this could lead to accelerated approval in the US.

Portfolio Pulse from Happy Mohamed

June 14, 2023 | 12:01 pm

AMRX

Amneal Pharmaceuticals has secured FDA approval for PEMRYDI RTU, a ready-to-use oncology injectable. The product is the first of its kind and does not require reconstitution, dilution, or refrigeration. It will be available in three vial sizes and is expected to launch in Q1 2024.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 12:01 pm

AAPL

AMZN

Apple's Watch Series 8 is now available at a $70 discount on Amazon, with prices starting at $329. The discount applies to both 41mm and 45mm models across all four colors.

Portfolio Pulse from Rounak Jain

June 14, 2023 | 12:00 pm

V

Visa has launched the Visa Africa Fintech Accelerator Program to support the growing start-up community in Africa. The program aims to provide resources, mentorship, and access to Visa's global network for fintech start-ups in the region.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 11:38 am

BWV

Blue Water Biotech acquires six FDA-approved drugs from WraSer and Xspire Pharma for $8.5 million, expanding its product portfolio across various treatments.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 11:35 am

NLSP

NLS Pharmaceutics announced positive safety data from in vitro CYP450 and transporter-mediated drug-drug interaction studies of Mazindol, showing a low risk for drug-drug interaction.

Portfolio Pulse from Benzinga Newsdesk

June 14, 2023 | 11:34 am